Cedar Wealth Management’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-143
Closed -$3.39K 276
2024
Q2
$3.39K Hold
143
﹤0.01% 267
2024
Q1
$4.36K Hold
143
﹤0.01% 290
2023
Q4
$4.9K Hold
143
﹤0.01% 241
2023
Q3
$9.35K Hold
143
﹤0.01% 230
2023
Q2
$11.4K Hold
143
﹤0.01% 231
2023
Q1
$11.7K Hold
143
﹤0.01% 226
2022
Q4
$12.2K Hold
143
0.01% 219
2022
Q3
$13K Hold
143
0.01% 236
2022
Q2
$17K Hold
143
0.01% 234
2022
Q1
$17K Buy
143
+68
+91% +$11.3K 0.01% 258
2021
Q4
$19K Buy
+75
New +$22.8K 0.01% 247

Other funds holding DRIO

Cedar Wealth Management's DRIO Position: Q3 2024 in Review

Cedar Wealth Management sold out of DarioHealth (DRIO) in Q3 2024, closing a stake of 143 shares — an estimated $3.39K sold.

Cedar Wealth Management first reported a position in DRIO in Q4 2021 and held it in 11 quarters. The position peaked at $19K in Q4 2021. 32 funds tracked by Wall St. Rank hold DRIO as of Q3 2024.

  • Cedar Wealth Management reported no remaining DarioHealth position as of Q3 2024 after selling out during the quarter.
  • Cedar Wealth Management sold 143 DarioHealth shares in Q3 2024, an estimated $3.39K.
  • Cedar Wealth Management first reported a position in DarioHealth in Q4 2021 and held it in 11 quarters.
  • Cedar Wealth Management's DarioHealth position peaked at $19K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held DarioHealth as of Q3 2024.

Based on Cedar Wealth Management's 13F filing for Q3 2024, filed 8 Nov 2024.